We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · October 25, 2020

ASCT for Untreated Transformed Indolent B‐Cell Lymphoma in First Remission

British Journal of Haematology


Additional Info

Disclosure statements are available on the authors' profiles:

British Journal of Haematology
Autologous Stem Cell Transplantation for Untreated Transformed Indolent B‐Cell Lymphoma in First Remission: An International, Multi‐Centre Propensity‐Score‐Matched Study
Br. J. Haematol 2020 Oct 16;[EPub Ahead of Print], CK Chin, KJ Lim, K Lewis, P Jain, Y Qing, L Feng, CY Cheah, JF Seymour, D Ritchie, K Burbury, CS Tam, NH Fowler, LE Fayad, JR Westin, SS Neelapu, FB Hagemeister, F Samaniego, CR Flowers, LJ Nastoupil, MJ Dickinson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading